Market Tracker

08/01 7:38am ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

131.91
Data as of Jul 31
 -3.35 / -2.48%
Today’s Change
64.93
Today|||52-Week Range
141.81
+46.66%
Year-to-Date

Today’s Trading

Previous close135.26
Today’s open134.12
Day’s range-- - --
Volume827,851
Average volume (3 months)1,098,822
Market cap$8.4B
Dividend yield--
Data as of 07/31/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+73.34%
Earnings growth (next 5 years)+18.40%
Revenue growth (last year)+26.98%
P/E ratio117.8
Price/Sales5.95
Price/Book11.21

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.65-1.17%
INCYIncyte Corp-1.80-3.65%
BMRNBiomarin Pharmaceuti...+0.73+1.19%
RDYDr.Reddy's Laborator...-1.89-4.05%
Data as of 07/31/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)$1.69
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts